Arti Masturzo, M.D., chief medical officer of CCS, spoke with Managed Healthcare Executive about the differences in coaching ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

The new chief medical officer of the Pulmonary Fibrosis Foundation speaks about patients in rural areas, research ...

The National Institutes of Mental Health states that serious mental illness affects 6% of U.S. adults, with young adults aged 18 to 25 experiencing the highest prevalence at 11.6%. Studies have shown ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

A protein called NF-kB c-Rel has been found to intensify the symptoms of psoriasis, offering a potential new target for ...

Researchers, physicians, families and affected patients view Duchenne muscular dystrophy (DMD) as a neuromuscular condition. Children are diagnosed during the first years of life because they have ...

Although the importance of ongoing education is known for patients, less than half of those with diabetes receive formal ...

Three Washington, D.C., healthcare policy experts and the former chief of staff of HHS dive into the healthcare politics and policies of the new administration: RFK Jr.’s confirmation hearings; the ...

Solid Biosciences reported recent positive data in developing their gene therapy candidate SGT-003. The phase 1/2 INSPIRE ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Simlandi and adalimumab-adaz have been with on formulary, along with Humira, beginning Jan. 1, 2025, Arpit Patel, Pharm.D., ...